Physician profile
Dragan Jevremovic
NPI 1003893686
$6,684.30
in general payments reported to CMS, 2019-2025
4 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.00 · 2022: $4,478 · 2023: $163 · 2024: $1,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,987 · Grant: $84.20 · Travel and Lodging: $72.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,986.57 |
| Grant | $84.20 |
| Travel and Lodging | $72.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,375.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $2,018.00 | 2019-2024 | |
| Genzyme Corporation | $186.86 | 2022-2023 | |
| Legend Biotech USA INC. | $104.44 | 2023-2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dragan Jevremovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.